Dai Ichi Life Insurance Company, LTD Seagen Inc. Transaction History

Dai Ichi Life Insurance Company, LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $578,681 - $636,075	3,084 Added 37.02%	11,415 $2.2 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $30,165 - $40,164	-223 Reduced 2.61%	8,331 $1.14 Million
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $2.44 Million - $4.02 Million	-22,393 Reduced 72.36%	8,554 $1.51 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $1.08 Million - $1.43 Million	-9,052 Reduced 22.63%	30,947 $4.46 Million
Q3 2021 Nov 04, 2021	BUY	$142.45 - $169.82 $2.53 Million - $3.01 Million	17,736 Added 79.67%	39,999 $6.79 Million

Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $580,033 - $691,763	4,294 Added 23.9%	22,263 $3.52 Million
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $1.32 Million - $1.83 Million	9,601 Added 114.73%	17,969 $2.5 Million
Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $1.38 Million - $1.77 Million	8,368 New	8,368 $1.47 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.